L26/P-366 Induced pluripotent stem cell-derived exosomes ameliorate endometrial fibrosis and immune dysregulation in intrauterine adhesion
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.701 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Q. Chen und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can Induced pluripotent stem cell-derived exosomes (iPSC-Exos) enhance fertility and reduce endometrial fibrosis in cases of intrauterine adhesion(IUA)? What mechanisms underlie their effects? Summary answer The iPSC-Exos reduces endometrial fibrosis in IUA and structural damage, thereby enhancing the local immune environment and leading to higher embryo implantation and survival rates. What is known already IUA is a global health issue that is closely associated with gynecological surgical procedures. Its incidence remains high and shows a year-on-year upward trend as the number of intrauterine surgeries increases. Although current standard treatments, such as hysteroscopic adhesiolysis, provide relief from adhesions, they often inadequately promote functional endometrial regeneration. They are associated with a notable recurrence rate. There is a pressing need to investigate innovative and effective clinical treatment strategies. iPSC-Exos have demonstrated potential in tissue repair. However, the long-term effects on fertility outcomes and the dose-response relationships in the treatment of IUA remain inadequately understood. Study design, size, duration The model of IUA was established using chemical injury. Female Sprague-Dawley rats, aged 6 to 8 weeks. 95% ethanol was infused into uterine horn, followed by thorough flushing with PBS. Rats were randomized into four groups (n = 9 per group): Control, Sham, Model, and iPSC-Exos. Uterine tissues were collected on day 14 post-injury for histological analysis. a subset of animals (n = 6 per group) were mated at the same time point to evaluate fertility restoration. Participants/materials, setting, methods Female rats were anesthetized with isoflurane, and the uterine horn was exposed. The 200 μL of 95% ethanol was infused for 2 min, followed by thorough flushing with PBS. 5 minutes post-modeling, the intervention group received an intrauterine injection of iPSC-Exos, while the model group received an equivalent volume of PBS. Uterine tissues were harvested for examination.Female rats were mated with male SD rats (1:1) two weeks post-surgery to record the number of viable pups. Main results and the role of chance Tissue Repair: Compared with the IUA group, the iPSC-Exos intervention group exhibited increased restoration of glandular and vascular numbers, significantly reduced collagen deposition, and a decreased fibrosis area percentage. Immunofluorescence analysis further showed attenuated fluorescence signals for Collagen I and Fibronectin following the intervention. Consistent with these findings, qPCR confirmed the downregulation of fibrosis markers(Collagen I, Fibronectin, and ECM1). Fertility Outcomes: The iPSC-Exos intervention group demonstrated a higher pregnancy rate and a higher average number of implantation sites compared to the model group, with healthy embryonic development observed at E13.5. Following natural delivery, the intervention group also exhibited increased litter size and live birth rate. Mechanistic Insights: Integrated analysis of public databases (GSE215968) identified 2480 significantly differentially expressed genes in endometrial stromal cells under IUA, revealing activation of immune and stress-related pathways such as cell migration and inflammatory response. Utilizing the conservation of genes across modules and integrating differential gene expression analysis, we identified seven candidate genes potentially pivotal in the disease process. The GO enrichment of these genes includes immune regulation and cytokine signaling pathways,suggesting that iPSC-Exos may participate in the repair process by modulating immune-related gene expression.These genes were validated in our intervention experiments, where their expression trends were consistent. Limitations, reasons for caution This study utilizes an animal model; therefore, additional validation is necessary before clinical application. Further research is required to elucidate the molecular mechanisms underlying fertility restoration, particularly the role of exosomes in regulating gene expression during embryo implantation and development. Increasing the sample size would improve statistical power. Wider implications of the findings The study indicates that iPSC-Exos are capable of structurally repairing damaged endometrium and significantly restoring reproductive function. These findings offer substantial preclinical evidence supporting the development of a novel IUA treatment strategy that integrates structural repair with functional reconstruction. Trial registration number No
Zitieren
APA
Chen, Q., Jiang, C., Ren, L., Wang, H., Feng, C., Sun, X., Wang, X., & Ma, X. (2026). L26/P-366 Induced pluripotent stem cell-derived exosomes ameliorate endometrial fibrosis and immune dysregulation in intrauterine adhesion. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.701
Vancouver
Chen Q, Jiang C, Ren L, Wang H, Feng C, Sun X, et al. L26/P-366 Induced pluripotent stem cell-derived exosomes ameliorate endometrial fibrosis and immune dysregulation in intrauterine adhesion. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.701
BibTeX
@article{Chen2026,
author = {Chen, Q. and Jiang, C. and Ren, L. and Wang, H. and Feng, C. and Sun, X. and Wang, X. and Ma, X.},
title = {L26/P-366 Induced pluripotent stem cell-derived exosomes ameliorate endometrial fibrosis and immune dysregulation in intrauterine adhesion},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.701}
}
EUVIMED